Language:

Specialty medications: traditional and novel tools can address rising spending on these costly drugs

Health Affairs, 2014-10, Vol.33 (10), p.1736-1744 [Peer Reviewed Journal]

Project HOPE—The People-to-People Health Foundation, Inc. ;Copyright The People to People Health Foundation, Inc., Project HOPE Oct 2014 ;ISSN: 0278-2715 ;EISSN: 1544-5208 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.2014.0511 ;PMID: 25288417

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Specialty medications: traditional and novel tools can address rising spending on these costly drugs
Author: Lotvin, Alan M ; Shrank, William H ; Singh, Surya C ; Falit, Benjamin P ; Brennan, Troyen A
Subjects: Antineoplastic Agents - economics ; Antineoplastic Agents - therapeutic use ; Biological Products - economics ; Cancer ; Cancer therapies ; Cost ; Cost control ; Cost Control - economics ; Cost Control - methods ; Costs ; Drug Costs - statistics & numerical data ; Drugs ; FDA approval ; Generic drugs ; Growth hormones ; Health Care Costs - statistics & numerical data ; Health care policy ; Health policy ; Hepatitis ; Humans ; Markets ; Monoclonal antibodies ; Multiple sclerosis ; Neoplasms - drug therapy ; Neoplasms - economics ; Patients ; Pharmaceutical industry ; Pharmaceuticals ; Pharmacy ; Population ; Prescription drugs ; Prescription Drugs - economics ; Prices ; Prostate cancer ; Reimbursement Mechanisms - economics ; Specialty products ; Studies ; Trends ; United States
Is Part Of: Health Affairs, 2014-10, Vol.33 (10), p.1736-1744
Description: Spending on specialty medications, which represented a small proportion of US pharmacy spending at the beginning of this decade, is growing by more than 15 percent annually. It is expected to account for approximately half ($235 billion) of total annual pharmacy spending by 2018. Among the numerous reasons for the high cost of this heterogeneous group of medications are the increasing size of target patient populations, the high cost of drug development, and a complex and uncoordinated delivery system. In this article we describe the evolution of the specialty market, characterize the current state of specialty medication use, and articulate key challenges and potential solutions. Fully realizing the potential value of the expanding universe of specialty medications will require collaborative efforts to reduce waste and promote value. Those who prescribe, dispense, deliver, and pay for specialty medications will need to employ a combination of traditional and novel management approaches, such as prior authorization, step therapy, tiered formularies, administration at lower-cost sites, and the unique tools being developed for cancer medications.
Publisher: United States: The People to People Health Foundation, Inc., Project HOPE
Language: English
Identifier: ISSN: 0278-2715
EISSN: 1544-5208
EISSN: 2694-233X
DOI: 10.1377/hlthaff.2014.0511
PMID: 25288417
Source: MEDLINE
ProQuest Central

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Specialty medications: traditional and novel tools can address rising spending on these costly drugs

Project HOPE—The People-to-People Health Foundation, Inc. ;Copyright The People to People Health Foundation, Inc., Project HOPE Oct 2014 ;ISSN: 0278-2715 ;EISSN: 1544-5208 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.2014.0511 ;PMID: 25288417

Searching Remote Databases, Please Wait